Ballerup, Denmark, January 7, 2026 – LEO Pharma, a global leader in medical dermatology, announced today that CEO Christophe Bourdon will deliver a company update at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026, at 9:30 AM PST.

With over 60 years of specialist expertise in medical dermatology and more than 90 million patients served in 70+ markets, LEO Pharma is uniquely positioned in one of healthcare’s most attractive and underserved sectors. Backed by an unmatched portfolio combining category‑leading brands with first‑in‑class innovations, the company is redefining standards of care for patients with high unmet needs.

Entering 2026, LEO Pharma builds on the strong momentum of recent years, marked by robust top-line growth, significant margin expansion, and a promising pipeline. Leveraging its unique global platform, the LEO Pharma is advancing innovation as the preferred partner in medical dermatology.

The J.P. Morgan Healthcare Conference presentation will provide investors, analysts, and partners with insights into LEO Pharma’s innovation strategy, growth momentum, and global ambitions in medical dermatology. Attendees can expect a high‑energy session that spotlights the company’s differentiated market position and outlines its next chapter of industry leadership.

Event details:

📍 Westin St. Francis Hotel, San Francisco
📅 Tuesday, January 13, 2026
🕘 9:30 AM PST